Fifteen new risk loci for coronary artery disease highlight arterial-wall-specific mechanisms

Nature Genetics

Volumn 49, Issue 7, 2017, Pages 1113-1119

  Howson, Joanna M M ^a   Zhao, Wei ^b   Barnes, Daniel R ^a   Ho, Weang Kee ^a,c   Young, Robin ^a,d   Paul, Dirk S ^a   Waite, Lindsay L ^e   Freitag, Daniel F ^a   Fauman, Eric B ^f   Salfati, Elias L ^g,h   Sun, Benjamin B ^a   Eicher, John D ^i,j   Johnson, Andrew D ^i,j   Sheu, Wayne H H ^k,l,m   Nielsen, Sune F ⁿ   Lin, Wei Yu ^a,o   Surendran, Praveen ^a   Malarstig, Anders ^p   Wilk, Jemma B ^f   Tybjærg Hansen, Anne ^q,r   Rasmussen, Katrine L ⁿ   Kamstrup, Pia R ⁿ   Deloukas, Panos ^s,t   Erdmann, Jeanette ^u,v,w   Kathiresan, Sekar ^x,y   Samani, Nilesh J ^z,aa   Schunkert, Heribert ^v,ab   Watkins, Hugh ^ac,ad   Do, Ron ^ae,af   Rader, Daniel J ^ag   Johnson, Julie A ^ah   Hazen, Stanley L ^ai   Quyyumi, Arshed A ^aj   Spertus, John A ^ak,al   Pepine, Carl J ^am   Franceschini, Nora ^an   Justice, Anne ^an   Reiner, Alex P ^ao   Buyske, Steven ^ap   Hindorff, Lucia A ^aq   Carty, Cara L ^ar   North, Kari E ^an,as   Kooperberg, Charles ^ar   Boerwinkle, Eric ^at,au   Young, Kristin ^an   Graff, Mariaelisa ^an   Peters, Ulrike ^ar   Absher, Devin ^e   Hsiung, Chao A ^k   Lee, Wen Jane ^av   Taylor, Kent D ^aw   Chen, Ying Hsiang ^k   Lee, I Te ^ax   Guo, Xiuqing ^aw   Chung, Ren Hua ^k   Hung, Yi Jen ^m,av   Rotter, Jerome I ^ay   Juang, Jyh Ming J ^az,ba   Quertermous, Thomas ^g,h   Wang, Tzung Dau ^az,ba   Rasheed, Asif ^bb   Frossard, Philippe ^bb   Alam, Dewan S ^bc   Majumder, Abdulla Al Shafi ^a   Di Angelantonio, Emanuele ^a,bd   Chowdhury, Rajiv ^a   Chen, Yii Der Ida ^aw   Nordestgaard, Børge G ^n,r   Assimes, Themistocles L ^g,h   Danesh, John ^a,bd   Butterworth, Adam S ^a,bd   Saleheen, Danish ^a,b,bb   more..

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF NOTTINGHAM MALAYSIA CAMPUS   (Malaysia)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

^e HUDSONALPHA INSTITUTE FOR BIOTECHNOLOGY   (United States)

^f PFIZER INC   (United States)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h STANFORD UNIVERSITY   (United States)

ⁱ NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^j FRAMINGHAM HEART STUDY   (United States)

^k TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^l NATIONAL YANG MING UNIVERSITY   (Taiwan)

^m NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

ⁿ GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^o NEWCASTLE UNIVERSITY   (United Kingdom)

^p Pfizer Worldwide Research and Development   (Sweden)

^q Rigshospitalet   (Denmark)

^r UNIVERSITY OF COPENHAGEN   (Denmark)

^s QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^t QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^u UNIVERSITY OF LÜBECK   (Germany)

^v DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^w University Heart Center Lübeck   (Germany)

^x MASSACHUSETTS GENERAL HOSPITAL   (United States)

^y HARVARD MEDICAL SCHOOL   (United States)

^z UNIVERSITY OF LEICESTER   (United Kingdom)

^aa GLENFIELD HOSPITAL   (United Kingdom)

^ab TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^ac UNIVERSITY OF OXFORD   (United Kingdom)

^ad UNIVERSITY OF OXFORD   (United Kingdom)

^ae MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^af UNIVERSITY OF PENNSYLVANIA   (United States)

^ag UNIVERSITY OF FLORIDA HEALTH   (United States)

^ah LERNER RESEARCH INSTITUTE   (United States)

^ai EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^aj SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^ak UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^al UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^am IL   (United States)

^an UNIVERSITY OF WASHINGTON   (United States)

^ao RUTGERS UNIVERSITY   (United States)

^ap NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^aq Fred Hutchinson Cancer Research Center   (United States)

^ar Carolina Center for Genome Sciences   (United States)

^as UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^at BAYLOR COLLEGE OF MEDICINE   (United States)

^au NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^av HARBOR UCLA MEDICAL CENTER   (United States)

^aw CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^ax TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^ay NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^az NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^ba Centre for Non Communicable Diseases   (Pakistan)

^bb YORK UNIVERSITY   (Canada)

^bc National Institute of Cardiovascular Diseases   (Bangladesh)

^bd WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; COL4A1 PROTEIN; COL4A2 PROTEIN; CXCL12 PROTEIN; ENDOTHELIAL PROTEIN C RECEPTOR; LMOD1 PROTEIN; PECAM1 PROTEIN; PHACTR1 PROTEIN; PROTEIN; PROTEIN C; UNCLASSIFIED DRUG;

ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL ADHESION; CORONARY ARTERY DISEASE; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; GENOTYPE; HUMAN; LEUKOCYTE MIGRATION; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; ARTERY; ENERGY METABOLISM; FEMALE; GENETIC PREDISPOSITION; GENETICS; HISTONE CODE; MALE; META ANALYSIS; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PATHOPHYSIOLOGY; RISK FACTOR; VASCULAR SMOOTH MUSCLE;

ARTERIES; ATHEROSCLEROSIS; CELL ADHESION; CHEMOTAXIS, LEUKOCYTE; CORONARY ARTERY DISEASE; ENERGY METABOLISM; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HISTONE CODE; HUMANS; MALE; MUSCLE, SMOOTH, VASCULAR; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; RISK FACTORS;

EID: 85021756461     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.3874     Document Type: Article

References (63)

1. Roth, G.A. et al. Demographic and epidemiologic drivers of global cardiovascular mortality. N. Engl. J. Med. 372, 1333-1341 (2015).
2. GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specifc all-cause and cause-specifc mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 385, 117-171 (2015).
3. CARDIoGRAMplusC4D Consortium. Large-scale association analysis identifes new risk loci for coronary artery disease. Nat. Genet. 45, 25-33 (2013).
4. Myocardial Infarction Genetics Consortium. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat. Genet. 41, 334-341 (2009).
5. IBC 50K CAD Consortium. Large-scale gene-centric analysis identifes novel variants for coronary artery disease. PLoS Genet. 7, e1002260 (2011).
6. Samani, N.J. et al. Genomewide association analysis of coronary artery disease. N. Engl. J. Med. 357, 443-453 (2007).
7. Schunkert, H. et al. Large-scale association analysis identifes 13 new susceptibility loci for coronary artery disease. Nat. Genet. 43, 333-338 (2011).
8. Erdmann, J. et al. New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat. Genet. 41, 280-282 (2009).
9. CARDIoGRAMplusC4D Consortium. A comprehensive 1000 Genomes-based genome-wide association meta- A nalysis of coronary artery disease. Nat. Genet. 47, 1121-1130 (2015).
10. Voight, B.F. et al. The Metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genet. 8, e1002793 (2012).
11. Segrè, A.V., Wei, N., Altshuler, D. & Florez, J.C. Pathways targeted by antidiabetes drugs are enriched for multiple genes associated with type 2 diabetes risk. Diabetes 64, 1470-1483 (2015).
12. GTEx Consortium. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348, 648-660 (2015).
13. Grundberg, E. et al. Mapping cis- and trans-regulatory effects across multiple tissues in twins. Nat. Genet. 44, 1084-1089 (2012).
14. Franzén, O. et al. Cardiometabolic risk loci share downstream cis- and trans-gene regulation across tissues and diseases. Science 353, 827-830 (2016).
15. Ward, L.D. & Kellis, M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 40, D930-D934 (2012).
16. Staley, J.R. et al. PhenoScanner: a database of human genotype-phenotype associations. Bioinformatics 32, 3207-3209 (2016).
17. Global Lipids Genetics Consortium. Discovery and refnement of loci associated with lipid levels. Nat. Genet. 45, 1274-1283 (2013).
18. Teslovich, T.M. et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707-713 (2010).
19. International Consortium for Blood Pressure Genome-Wide Association Studies. Genetic variants in novel pathways infuence blood pressure and cardiovascular disease risk. Nature 478, 103-109 (2011).
20. Surendran, P. et al. Trans- A ncestry meta- A nalyses identify rare and common variants associated with blood pressure and hypertension. Nat. Genet. 48, 1151-1161 (2016).
21. Zanoni, P. et al. Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease. Science 351, 1166-1171 (2016).
22. Boettger, L.M. et al. Recurring exon deletions in the HP (haptoglobin) gene contribute to lower blood cholesterol levels. Nat. Genet. 48, 359-366 (2016).
23. Johansson, Å. et al. Identification of genetic variants infuencing the human plasma proteome. Proc. Natl. Acad. Sci. USA 110, 4673-4678 (2013).
24. Holme, I., Aastveit, A.H., Hammar, N., Jungner, I. & Walldius, G. Haptoglobin and risk of myocardial infarction, stroke, and congestive heart failure in 342,125 men and women in the Apolipoprotein MOrtality RISk study (AMORIS). Ann. Med. 41, 522-532 (2009).
25. Levy, A.P. et al. Haptoglobin genotype is a determinant of iron, lipid peroxidation, and macrophage accumulation in the atherosclerotic plaque. Arterioscler. Thromb. Vasc. Biol. 27, 134-140 (2007).
26. Westra, H.J. et al. Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat. Genet. 45, 1238-1243 (2013).
27. Dennis, J. et al. The endothelial protein C receptor (PROCR) Ser219Gly variant and risk of common thrombotic disorders: a HuGE review and meta- A nalysis of evidence from observational studies. Blood 119, 2392-2400 (2012).
28. Tang, W. et al. Genome-wide association study identifes novel loci for plasma levels of protein C: the ARIC study. Blood 116, 5032-5036 (2010).
29. Smith, N.L. et al. Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: the CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium. Circulation 121, 1382-1392 (2010).
30. Qu, D., Wang, Y., Song, Y., Esmon, N.L. & Esmon, C.T. The Ser219->Gly dimorphism of the endothelial protein C receptor contributes to the higher soluble protein levels observed in individuals with the A3 haplotype. J. Thromb. Haemost. 4, 229-235 (2006).
31. Reiner, A.P. et al. PROC, PROCR and PROS1 polymorphisms, plasma anticoagulant phenotypes, and risk of cardiovascular disease and mortality in older adults: the Cardiovascular Health Study. J. Thromb. Haemost. 6, 1625-1632 (2008).
32. Uhlen, M. et al. Towards a knowledge-based Human Protein Atlas. Nat. Biotechnol. 28, 1248-1250 (2010).
33. Uhlén, M. et al. Tissue-based map of the human proteome. Science 347, 1260419 (2015).
34. Greenawalt, D.M. et al. A survey of the genetics of stomach, liver, and adipose gene expression from a morbidly obese cohort. Genome Res. 21, 1008-1016 (2011).
35. Nanda, V. & Miano, J.M. Leiomodin 1, a new serum response factor-dependent target gene expressed preferentially in differentiated smooth muscle cells. J. Biol. Chem. 287, 2459-2467 (2012).
36. Chen, J., Kitchen, C.M., Streb, J.W. & Miano, J.M. Myocardin: a component of a molecular switch for smooth muscle differentiation. J. Mol. Cell. Cardiol. 34, 1345-1356 (2002).
37. Wang, Z., Wang, D.Z., Pipes, G.C. & Olson, E.N. Myocardin is a master regulator of smooth muscle gene expression. Proc. Natl. Acad. Sci. USA 100, 7129-7134 (2003).
38. Kirsten, H. et al. Dissecting the genetics of the human transcriptome identifes novel trait-related trans-eQTLs and corroborates the regulatory relevance of non-protein coding loci. Hum. Mol. Genet. 24, 4746-4763 (2015).
39. Fairfax, B.P. et al. Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression. Science 343, 1246949 (2014).
40. Privratsky, J.R. et al. Relative contribution of PECAM-1 adhesion and signaling to the maintenance of vascular integrity. J. Cell Sci. 124, 1477-1485 (2011).
41. Harry, B.L. et al. Endothelial cell PECAM-1 promotes atherosclerotic lesions in areas of disturbed fow in ApoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 28, 2003-2008 (2008).
42. Goel, R. et al. Site-specifc effects of PECAM-1 on atherosclerosis in LDL receptor- deficient mice. Arterioscler. Thromb. Vasc. Biol. 28, 1996-2002 (2008).
43. Lappalainen, T. et al. Transcriptome and genome sequencing uncovers functional variation in humans. Nature 501, 506-511 (2013).
44. Zeller, T. et al. Genetics and beyond-the transcriptome of human monocytes and disease susceptibility. PLoS One 5, e10693 (2010).
45. Schröder, A. et al. Genomics of ADME gene expression: mapping expression quantitative trait loci relevant for absorption, distribution, metabolism and excretion of drugs in human liver. Pharmacogenomics J. 13, 12-20 (2013).
46. Schadt, E.E. et al. Mapping the genetic architecture of gene expression in human liver. PLoS Biol. 6, e107 (2008).
47. Lin, H. et al. Gene expression and genetic variation in human atria. Heart Rhythm 11, 266-271 (2014).
48. Narahara, M. et al. Large-scale East-Asian eQTL mapping reveals novel candidate genes for LD mapping and the genomic landscape of transcriptional effects of sequence variants. PLoS One 9, e100924 (2014).
49. Innocenti, F. et al. Identification, replication, and functional fne-mapping of expression quantitative trait loci in primary human liver tissue. PLoS Genet. 7, e1002078 (2011).
50. Assimes, T.L. et al. Genetics of coronary artery disease in Taiwan: a cardiometabochip study by the Taichi Consortium. PLoS One 11, e0138014 (2016).
51. Franceschini, N. et al. Prospective associations of coronary heart disease loci in African Americans using the MetaboChip: the PAGE study. PLoS One 9, e113203 (2014).
52. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559-575 (2007).
53. Zhou, X. & Stephens, M. Genome-wide efficient mixed-model analysis for association studies. Nat. Genet. 44, 821-824 (2012).
54. Willer, C.J., Li, Y. & Abecasis, G.R. METAL: fast and efficient meta- A nalysis of genomewide association scans. Bioinformatics 26, 2190-2191 (2010).
55. Morris, A.P. Transethnic meta- A nalysis of genomewide association studies. Genet. Epidemiol. 35, 809-822 (2011).
56. Yang, J. et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifes additional variants infuencing complex traits. Nat. Genet. 44, 369-375 (2012).
57. Zhang, X. et al. Synthesis of 53 tissue and cell line expression QTL datasets reveals master eQTLs. BMC Genomics 15, 532 (2014).
58. Ernst, J. & Kellis, M. Discovery and characterization of chromatin states for systematic annotation of the human genome. Nat. Biotechnol. 28, 817-825 (2010).
59. Ernst, J. & Kellis, M. ChromHMM: automating chromatin-state discovery and characterization. Nat. Methods 9, 215-216 (2012).
60. Moore, C. et al. The INTERVAL trial to determine whether intervals between blood donations can be safely and acceptably decreased to optimise blood supply: study protocol for a randomised controlled trial. Trials 15, 363 (2014).
61. Astle, W.J. et al. The allelic landscape of human blood cell trait variation and links to common complex disease. Cell 167, 1415-1429 (2016).
62. Abecasis, G.R. et al. A map of human genome variation from population-scale sequencing. Nature 467, 1061-1073 (2010).
63. Arnold, M., Raffer, J., Pfeufer, A., Suhre, K. & Kastenmüller, G. SNiPA: an interactive, genetic variant-centered annotation browser. Bioinformatics 31, 1334-1336 (2015).